Isabel. Rubio-Aliaga, et.al., Dll1 haploinsufficiency in adult mice leads to a complex phenotype affecting metabolic and immunological processes., PloS one, 2009, 4

http://rdf.ncbi.nlm.nih.gov/pubmed/19562077

Isabel. Rubio-Aliaga, et.al., Dll1 haploinsufficiency in adult mice leads to a complex phenotype affecting metabolic and immunological processes., PloS one, 2009, 4

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Dll1<m1Mhda>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4821259

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased circulating total protein level_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0005567C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• hyperactivity_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0001399C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• decreased circulating triglyceride level_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0002644C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased food intake_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0011940C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• abnormal Q wave_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0010515C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased CD8-positive, alpha-beta T cell number_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0008078C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased basal metabolism_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0008965C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• decreased circulating cholesterol level_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0005179C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• increased blood uric acid level_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0008821C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• decreased circulating triglyceride level_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0002644C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• premature death_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0002083C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• preweaning lethality, incomplete penetrance_Dll1<m1Mhda>/Dll1<m1Mhda>
  http://metadb.riken.jp/0011110C3HeBFeJDll1m1MhdaDll1m1MhdaDll1m1MhdaDll1m1Mhda
• decreased IgG2b level_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0008497C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased body weight_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0001262C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased mean systemic arterial blood pressure_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0004875C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased susceptibility to weight loss_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0010180C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased bone mineral density_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0000062C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased body weight_Dll1<m1Mhda>/Dll1<m1Mhda>
  http://metadb.riken.jp/0001262C3HeBFeJDll1m1MhdaDll1m1MhdaDll1m1MhdaDll1m1Mhda
• abnormal defecation_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0003866C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased basal metabolism_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0008965C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased CD4-positive, alpha beta T cell number_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0008075C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased IgG3 level_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0008498C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased B cell number_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0005014I129S1Sv129X1SvJDll1tm1GosDll1Dll1tm1GosDll1
• increased lean body mass_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0003960C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• increased systemic arterial systolic blood pressure_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0006144C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• decreased lumbar vertebrae number_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0004647C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased systemic arterial diastolic blood pressure_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0006143C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased bone mineral density_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0000063C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• decreased body height_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0001255C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased total body fat amount_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0010025C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased body weight_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0001262C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• increased systemic arterial systolic blood pressure_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0006144C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• abnormal bone mineral density_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0010119I129S1Sv129X1SvJDll1tm1GosDll1Dll1tm1GosDll1
• decreased body height_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0001255C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• decreased heart rate_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0005333C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• abnormal enzyme/coenzyme activity_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0005584C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased heart rate_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0005333C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased mean systemic arterial blood pressure_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0004875C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• decreased circulating cholesterol level_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0005179C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased susceptibility to weight loss_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0010180I129S1Sv129X1SvJDll1tm1GosDll1Dll1tm1GosDll1
• decreased lean body mass_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0003961C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased CD4-positive, alpha beta T cell number_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0008075I129S1Sv129X1SvJDll1tm1GosDll1Dll1tm1GosDll1
• decreased B-1 B cell number_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0004978C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased IgA level_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0001807C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased B cell number_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0005014C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased total body fat amount_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0010025C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• increased systemic arterial diastolic blood pressure_Dll1<m1Mhda>/Dll1<+>
  http://metadb.riken.jp/0006143C3HeBFeJDll1m1MhdaDll1m1MhdaDll1Dll1m1MhdaDll1
• decreased CD8-positive, alpha-beta T cell number_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0008079C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased IgG1 level_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0008495C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• hypoactivity_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0001402C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased blood uric acid level_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0008822C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• decreased basal metabolism_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0020234C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1
• increased basal metabolism_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0008965I129S1Sv129X1SvJDll1tm1GosDll1Dll1tm1GosDll1
• decreased bone mineral density_Dll1<tm1Gos>/Dll1<+>
  http://metadb.riken.jp/0000063C3Fe129Dll1tm1GosDll1tm1GosDll1Dll1tm1GosDll1

class

http://purl.org/net/cito/citesAsAuthority

• Dll1<m1Mhda>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4821259